Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eufloria Medical is a regenerative medicine company that develops and distributes human birth tissue-derived biologics. The company specializes in amniotic fluid allografts and membranes, which are utilized in clinical settings for orthopedics, wound care, and pain management. Their products, such as Eufloria and Eufloria Flow, are processed to retain high concentrations of cytokines, growth factors, and extracellular matrix proteins to facilitate tissue repair and reduce inflammation. Eufloria Medical operates under FDA HCT/P regulations, focusing on providing minimally manipulated tissues for homologous use. The company aims to provide clinicians with advanced biologic tools to enhance patient recovery and improve outcomes in regenerative therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eufloria Medical.